Information Provided By: 
Fly News Breaks for June 22, 2015
ZIOP
Jun 22, 2015 | 07:59 EDT
As noted earlier, BMO Capital downgraded Ziopharm Market Perform from Outperform. As reasons for the downgrade, the firm cited valuation, increased competition, and its belief that the company has fallen further behind its competitors. Target to $10 from $15.
News For ZIOP From the Last 2 Days
There are no results for your query ZIOP
